Sheffield, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of a synthetic biology platform designed to provide the design and manufacturing of next-generation biomedicines and bioprocesses. Syngensys is based in Sheffield, United Kingdom and was founded in 2021. Its last reported valuation was $8.6 million in Apr 2025. It has raised $4.1 million.
Last reported valuation
$8.6M
Oct 2026
Priced at
—
Total raised
$4.1M
Last round
—
Team — not yet on record
No current team members for Syngensys are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Syngensys with a free account
·Watch Syngensys: the Monday email on marks, rounds and moves
